Abstract:The beta-amyloid hypothesis of Alzheimer's disease (AD) has resulted in current research focusing on lowering levels of brain beta-amyloid, a small peptide derived from amyloid precursor protein. Meanwhile, the signaling pathways downstream of beta-amyloid as well as beta-amyloid-independent mechanisms are also being vigorously pursued as potential disease-modifying targets. One such potential target is the protein kinase GCN2, which is important in controlling mRNA translation via phosphorylation of eukaryotic initiation factor 2α subunit (eIF2α). Interestingly, elevated eIF2α phosphorylation has been correlated with AD pathogenesis, potentially via mechanisms of oxidative stress. Here taking advantage of a mutant mouse model in which eIF2 a kinase GCN2 is deleted (GCN2 KO), we examined whether repression of eIF2α phosphorylation could alleviate synaptic and memory deficits associated with APP/PS1 AD model mice. Hippocampal long-term potentiation (LTP) was induced by high frequency-stimulation (HFS) at CA3-CA1 synapses. Spatial memory was estimated by doing Morris water maze. Immunofluorescence combined with confocal microscopy was used to detect dendritic co-localization. Western blot was used to examine regulation of protein levels. We found that phosphorylation of eIF2α was increased in human AD brains and in the hippocampus of APP/PS1 mutant mice, which are a model for AD. We also found that the increase in eIF2 a phosphorylation in the APP/PS1 mice was correlated with increases in the levels of GCN2 and ATF4 (activating transcription factor 4). Additionally, we found that GCN2 co-localized with phospho-eIF2α in dendritic processes of hippocampal neurons. In correlation, hippocampal LTP was intact in GCN2 KO mice treated with beta-amyloid 1–42 (500 nM), which caused LTP failure in wild type mice. Furthermore, we crossed APP/PS1 mouse with GCN2 KO mice and generated APP/PS1/GCN2 KO double mutant mice. We demonstrated that inhibition of eIF2α activity by deleting GCN2 prevented decline of spatial memory and synaptic function in APP/PS1 mouse (10–12 month old). Our findings indicate that AD-associated impairments in synaptic plasticity and memory can be prevented by decreasing GCN2-dependent eIF2 a phosphorylation, which might be linked to enhanced translation. These studies suggest that GCN2 and eIF2a are viable therapeutic targets for synaptic dysfunction in AD and other related dementia syndrome.

N-myc downstream-regulated gene 2 deficiency aggravates memory impairment in Alzheimer's disease

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

Electroacupuncture Attenuates Reference Memory Impairment Associated with Astrocytic NDRG2 Suppression in APP/PS1 Transgenic Mice.

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.

O3–02–01: Reversal of Synaptic Plasticity and Spatial Memory Deficits in APP/PS1 Mice by Suppressing Protein Kinase GCN2

Astrocytic NDRG2 is a potential guarder for diabetes-associated cognitive dysfunction via regulating complement C3 cascades

Upregulation of Wnt2b Produces Neuroprotective Effects by Alleviating Mitochondrial Dysfunction in Alzheimer’s Disease

Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.

Neuregulin 1 Improves Cognitive Deficits and Neuropathology in an Alzheimer'S Disease Model

MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease <italic>in vivo</italic> and<?A3B2 ACK?><italic>in vitro</italic>

Interaction Between TRPML1 and P62 in Regulating Autophagosome-Lysosome Fusion and Impeding Neuroaxonal Dystrophy in Alzheimer’s Disease

Mir-135A-5p Mediates Memory and Synaptic Impairments Via the Rock2/Adducin1 Signaling Pathway in a Mouse Model of Alzheimer’s Disease

The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia

NDRG2 Protects the Brain from Excitotoxicity by Facilitating Interstitial Glutamate Uptake.

A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.

Inflammasome-mediated neurodegeneration following heart disease

NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE